TRCT
GRDN

Tower Research Capital (TRC)’s Guardian Pharmacy Services GRDN Stock Holding History

Tower Research Capital (TRC)’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.6K Buy
1,477
+93
+7% +$3.04K ﹤0.01% 2653
2025
Q4 		$41.6K Buy
1,384
+300
+28% +$8.49K ﹤0.01% 2566
2025
Q3 		$28.4K Sell
1,084
-392
-27% -$9.34K ﹤0.01% 2991
2025
Q2 		$31.5K Buy
1,476
+917
+164% +$20.7K ﹤0.01% 3361
2025
Q1 		$11.9K Buy
559
+69
+14% +$1.42K ﹤0.01% 3493
2024
Q4 		$9.93K Buy
+490
New +$10.1K ﹤0.01% 3859

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Tower Research Capital (TRC)'s GRDN Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Guardian Pharmacy Services (GRDN) stake by 6.7% in Q1 2026, buying an estimated $3.04K and bringing the position to 1,477 shares worth $55.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Tower Research Capital (TRC) first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • Tower Research Capital (TRC) held 1,477 shares of Guardian Pharmacy Services worth $55.6K as of Q1 2026.
  • Tower Research Capital (TRC) bought 93 Guardian Pharmacy Services shares in Q1 2026, an estimated $3.04K.
  • Guardian Pharmacy Services made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2653 holding.
  • Tower Research Capital (TRC) first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.